首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi.
【24h】

Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi.

机译:PTPα和SRC RNAi雌激素受体阴性乳腺癌和结肠癌细胞凋亡的凋亡。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We show that siRNA-mediated suppression of protein tyrosine phosphatase alpha (PTP alpha) reduces Src activity 2 to 4-fold in breast, colon and other human cancer cell lines. Src and PTP alpha RNAi induced apoptosis in estrogen receptor (ER)-negative breast cancer and colon cancer cells, but not in immortalized noncancerous breast cells, ER-positive breast cancer cells or other cancer cell types tested. RNAi of other Src family members (Fyn and Yes) or of PTP1B, a phosphatase previously suggested to be an activator of Src in breast cancer, had no effect. Although further tests with primary tumor tissues are required, the unexpected correlation between ER status and Src/PTP alpha dependence in breast cancer cell lines may be important for planning therapeutic strategies, and the insensitivity of normal breast cells to the RNAi highlights the potential of PTP alpha, which may be easier to target than Src, as a therapeutic target in ER-negative breast cancer.
机译:我们表明siRNA介导的蛋白酪氨酸磷酸酶α(PTPα)抑制乳腺,结肠和其他人类癌细胞系中的SRC活性2至4倍。 SRC和PTPαRNAi诱导雌激素受体(ER) - 儿童乳腺癌和结肠癌细胞的细胞凋亡,但不成时成的非癌症乳腺细胞,ER阳性乳腺癌细胞或其他癌细胞类型测试。 其他SRC系列成员(FYN和YES)或PTP1B的RNAi,先前表明是乳腺癌中SRC活化剂的磷酸酶无效。 尽管需要具有原发性肿瘤组织的进一步测试,但ER状态和SRC / PTPα之间的意外相关性对于乳腺癌细胞系依赖性对于规划治疗策略来说可能是重要的,并且正常乳房细胞对RNAi的不敏感性突出了PTP的潜力 α,其比SRC更容易靶向,作为ER阴性乳腺癌中的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号